Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells-Reference-Cited by-同舟云学术

Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells

Published:2015-11-23 Issue:1 Volume:17 Page:65-75
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Duerr Claudia U,McCarthy Connor D A,Mindt Barbara C,Rubio Manuel,Meli Alexandre P,Pothlichet Julien,Eva Megan M,Gauchat Jean-François,Qureshi Salman T,Mazer Bruce D,Mossman Karen L,Malo Danielle,Gamero Ana M,Vidal Silvia M,King Irah L,Sarfati Marika,Fritz Jörg H

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/ni.3308.pdf

Reference54 articles.

1. Gause, W.C., Wynn, T.A. & Allen, J.E. Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths. Nat. Rev. Immunol. 13, 607–614 (2013).

2. Hoyler, T. et al. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37, 634–648 (2012).

3. Spits, H. et al. Innate lymphoid cells–a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145–149 (2013).

4. Diefenbach, A., Colonna, M. & Koyasu, S. Development, differentiation, and diversity of innate lymphoid cells. Immunity 41, 354–365 (2014).

5. McKenzie, A.N., Spits, H. & Eberl, G. Innate lymphoid cells in inflammation and immunity. Immunity 41, 366–374 (2014).

Cited by 285 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress on the role and inhibitors of Keap1 signaling pathway in inflammation;International Immunopharmacology;2024-11

2. Interplay between pulmonary epithelial stem cells and innate immune cells contribute to the repair and regeneration of ALI/ARDS;Translational Research;2024-10

3. Sulfotransferase homolog 2 receptors blockade on monocyte subsets along with their inflammatory cytokines for septic lung injury;Experimental Lung Research;2024-09-06

4. ILC2-derived LIF licences progress from tissue to systemic immunity;Nature;2024-08-07

5. Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma;Allergy;2024-08